Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism
- PMID: 6281332
Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism
Abstract
For biochemical characterization, the first component of human complement (C1) was reconstituted from physiologic concentrations of purified C1q, 125I C1r, and 131I C1s. Upon incubation at 37 degrees C, C1 spontaneously activated, as evidenced by the characteristic proteolysis of the C1r and C1s polypeptide chains as detected by SDS-PAGE analysis. This spontaneous C1 activation followed first-order kinetics (t 1/2 = 4 min and k = 0.173 min-1) with an activation energy of 19.1 kcal/mol. Spontaneous C1 activation was unaffected by the general protease inhibitor phenylmethylsulfonylfluoride (PMSF) but reversibly blocked by a known inhibitor of C1 activation, nitrophenylguanidinobenzoate (NPGB). Spontaneous C1 activation was measured at C1 concentrations ranging from 9 to 160 nM (i.e., 0.05 to 1.0 times physiologic concentrations). The data indicate that C1 spontaneously activates by an intramolecular autocatalytic mechanism, for first-order kinetics were observed over the entire concentration range with t 1/2 = 4 min at each concentration. However, the percentage of activable C1 decreased with dilution due to C1 dissociation (i.e., C1qr2s2 leads to C1q + C1r2s2). The observed concentration of C1 that spontaneously activated at each dilution equalled the concentration of C1 present as macromolecular C1. When reconstituted C1 was mixed with normal human serum (NHS) and then incubated at 37 degrees C, spontaneous C1 activation was completely inhibited. Pretreating NHS at 56 degrees C for 30 min destroyed its inhibitory activity. In conclusion, C1 spontaneously autoactivates at 37 degrees C by an intramolecular mechanism. This activation is suppressed in NHS.
Similar articles
-
A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.J Immunol. 1988 Dec 1;141(11):3930-6. J Immunol. 1988. PMID: 3183385
-
C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.J Immunol. 1987 Dec 15;139(12):4145-51. J Immunol. 1987. PMID: 2826582
-
Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.J Immunol. 1986 Jul 1;137(1):255-62. J Immunol. 1986. PMID: 3486914
-
C1 subcomponent complexes: basic and clinical aspects.Behring Inst Mitt. 1993 Dec;(93):292-8. Behring Inst Mitt. 1993. PMID: 8172579 Review.
-
The first component of human complement (C1): activation and control.Springer Semin Immunopathol. 1983;6(2-3):213-30. doi: 10.1007/BF00205874. Springer Semin Immunopathol. 1983. PMID: 6314572 Review.
Cited by
-
Blocking activation of the C1r zymogen defines a novel mode of complement inhibition.J Biol Chem. 2025 Mar;301(3):108301. doi: 10.1016/j.jbc.2025.108301. Epub 2025 Feb 11. J Biol Chem. 2025. PMID: 39947467 Free PMC article.
-
Anti-inflammatory effects of C1-Inhibitor in porcine and human whole blood are independent of its protease inhibition activity.Innate Immun. 2010 Aug;16(4):254-64. doi: 10.1177/1753425909340420. Epub 2009 Aug 26. Innate Immun. 2010. PMID: 19710096 Free PMC article.
-
The interaction between the complement system and hemostatic factors.Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605. Curr Opin Hematol. 2020. PMID: 32701617 Free PMC article. Review.
-
Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex.PLoS Pathog. 2016 Jan 25;12(1):e1005404. doi: 10.1371/journal.ppat.1005404. eCollection 2016 Jan. PLoS Pathog. 2016. PMID: 26808924 Free PMC article.
-
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.Clin Rev Allergy Immunol. 2016 Oct;51(2):207-15. doi: 10.1007/s12016-016-8555-6. Clin Rev Allergy Immunol. 2016. PMID: 27273087 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous